Press Releases

Veteran advisor to CEOs and boards brings decades of leadership, strategy and financial services experience Neptune Insurance Holdings, Inc. (NYSE:NP), the parent company of Neptune Flood Incorporated, a leading AI-native managing general agent, today announced that David Noble has been appointed as an independent member to its Board of Directors, effective September 30, 2026. Noble founded VIEW Advisors, which advises CEOs, their leadership teams, boards of directors and investors around the world on leadership and strategy. He is a senior advisor to Egon Zehnder, and the Institute of Coaching (a Harvard Medical School affiliate) and sits on the boards of Amylu Foods and Demakes Bros.

ORINDA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (NASDAQ:MKZR) ("MacKenzie" or the "Company") today announced its financial results for the year ended June 30, 2026 and announced that its Board has temporarily suspended the Preferred Share Repurchase Program while it explores strategic transactions such as reverse takeovers.  Key Financial Highlights:Operating Results for the Year Ended June 30, 2026: Net revenues for year ended June 30, 2026, were $20.01 million, a decrease of 9% from $22.06 million in the same period of 2025.Net operating loss was $15.61 million, a decrease of 33% as compared to a net operating loss of $23.46 million in the same period

GLEN ALLEN, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company") today announced that the Company’s Compensation Committee has granted a new employee stock option to purchase 155,446 shares of common stock as an inducement to such person becoming an employee of the Company. The option award has an exercise price of $4.22 per share, the closing price of the Company’s common stock on September 25, 2026, the effective date of grant and has a ten-year term. The option award will vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments thereafter, subject to

Saba Capital Income & Opportunities Fund (NYSE:BRW) (the "Fund"), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the "Investment Company Act"). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the Investment Company Act, the Fund is providing its shareholders with an estimate of the source of the Fund's monthly distribution as required by current securities laws. The Fund’s estimated sources of the distribution to be paid

Saba Capital Income & Opportunities Fund II (NYSE:SABA) (the "Fund"), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the "Investment Company Act"). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the Investment Company Act, the Fund is providing its shareholders with an estimate of the source of the Fund's monthly distribution as required by current securities laws. The Fund’s estimated sources of the distribution to be

TORONTO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Limited (("Xanadu", TSX:XNDU), a leading photonic quantum computing company, today announced that Rafal Janik, Xanadu's Chief Operating Officer, has entered into an automatic securities disposition plan (the "Plan") to sell Class B Subordinate Voting Shares of Xanadu ("Class B Shares") held directly by Mr. Janik. The Plan has been adopted in accordance with applicable securities laws and Xanadu’s internal policies. Sales of Class B Shares under the Plan are eligible to commence on or after December 29, 2026. The Plan was entered into when Mr. Janik was not in possession of material non-public information regarding Xan

The project brings essential infrastructure to a fast-growing region in the U.S.1, aimed to support economic growth and mobilityAMSTERDAM, Sept. 30, 2026 /PRNewswire/ -- Ferrovial, a leading global infrastructure company, announces that commercial close has been reached with the Tennessee Department of Transportation (TDOT) for the I-24 Southeast Choice Lanes in Nashville. This milestone establishes the contractual framework for one of Tennessee's most transformative transportation initiatives, marking the state's largest single capital investment and first public-private partnership in its history.Under the agreement, the Ferrovial-led DriveTN consortium will finance, design, build, operate

CAMZYOS is the only FDA-approved therapy for the treatment of oHCM in a pediatric population Approval based on positive results of Phase 3 SCOUT-HCM trial, building on the extensive clinical evidence for CAMZYOS in adults with oHCM Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved CAMZYOS® (mavacamten) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms in adults and pediatric patients weighing 30 kg (66 lbs) or more. CAMZYOS now has the broadest indication of any cardiac myosin inhibitor (CMI). This expanded indication offers a new treatment option for patient

Oculis Announces Resignation of Lionel Carnot from Board of Directors ZUG, Switzerland, September 30, 2026 -- Oculis Holding AG (NASDAQ:OCS) ("Oculis" or the "Company"), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announces that director Lionel Carnot will be resigning from the Board of Directors, effective today, after nearly a decade of dedicated service since 2017. Anthony Rosenberg, Chair of the Board, remarked: "On behalf of the Board and the entire Oculis team, we wish to extend our sincere gratitude to Lionel for his invaluable service, leadership and guidance over n

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) ("Bright Minds" or the "Company"), a clinical stage biotechnology company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, Prader-Willi Syndrome, depression, and other central nervous system (CNS) disorders, today announced that it will participate in the Foundation for Prader-Willi Research (FPWR) 2026 Research Symposium, October 7-8, and the PWS Family Conference, October 9-10, at the Marriott Philadelphia Downtown. The FPWR meeting brings together families, caregivers, clinicians, researchers, and industry to share the latest in PWS rese

MEXICO CITY, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE:AERO, BMV:AERO) ("Aeroméxico") will hold a live conference call and webcast on Tuesday, October 20, 2026, at 8:00 a.m. Mexico City Time (10:00 a.m. Eastern Time) to discuss its third quarter 2026 financial results. During the call, management will review the company’s operating and financial performance for the period, highlighting key business drivers, recent developments, and strategic initiatives that shaped Aeroméxico’s results throughout the third quarter. The event will also include a Q&A session for investors and analysts. A live webcast of this event will be available at ir.aeromexico.com and an

HOUSTON, Sept. 30, 2026 /PRNewswire/ -- KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) ("KLX" or the "Company") announced today that, on September 29, 2026, it completed its previously announced subscription rights offering (the "Rights Offering"), which expired at 5:00 p.m., New York City time, on September 23, 2026, and closed the Backstop Exchange (as defined below). Pursuant to the terms of the Rights Offering, 24,975,001 shares of the Company's common stock, par value $0.01 per share (the "Common Stock"), were purchased pursuant to the exercise of subscription rights at the subscription price of $1.49 per whole share (the "Subscription Price") for gross proceeds of $37.2 million to th

Strategic Expansion into Photonic Computing via LightSolver Acquisition Diversifies Technology Portfolio Alongside Continued Innovations in Regenerative MedicineREHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), today announced financial results for the second quarter of 2026 and provided a corporate update.Yehiel Tal, CollPlant's Chief Executive Officer, commented: "The acquisition of LightSolver marks CollPlant's strategic entry into high-performance computing (HPC) and photonics computing markets, alongside our regenerative medicine activities. LightSolver's pioneering LPU technology, recently validated in a peer-reviewed study with Germany's HLRS dem

LOS ANGELES, CA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "we" or "us" or "IMMX"), a global leader in relapsed/refractory AL Amyloidosis, today announced the closing of its previously announced underwritten registered offering of 11,363,637 shares of its common stock at a public offering price of $11.00 per share. The net proceeds to Immix from the offering, after deducting the underwriting discounts, commissions and other offering expenses, were approximately $117.1 million. Immix intends to use the net proceeds from this offering to fund NXC-201 development, working capital and general corporate purposes. J.P. Morgan acted as the sole book-runnin

WISeKey Reports First Half 2026 Financial Results, Accelerates Quantum and Post-Quantum Strategy and Provides Outlook Schedules Conference Call for Thursday, October 1 at 9:00am ET H1 2026 Unaudited Revenue Up Approximately 116% to $11.4 MillionApproximately $495 Million in Cash and Restricted Cash at June 30, 2026SEALSQ Commercial Pipeline Exceeds $225 Million Through 2029FY 2026 Revenue Growth Guidance of 50% to 100% ReaffirmedShareholders Approved Redomiciliation; Direct Nasdaq and SIX Listing as WISeQey (WQEY) Expected in OctoberStrategic Progress Includes WISeSat and Quantisimo Transactions, Commercial QSOC Deployment, SEALQuantum Expansion and New Swiss Post-Quantum Semiconductor Cen

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20260930898076/en/ INVESTOR CONTACT: Frank

Nu Holdings Ltd. (NYSE:NU) ("Nu" or the "Company") refers to recent media reports regarding a potential transaction. As a matter of general practice, the Company does not comment on specific opportunities. However, given the extent of recent media speculation, the Company is providing this clarification: while we have a great deal of respect for Monzo, the Company is not pursuing a transaction with Monzo. In the normal course of business, Nu regularly evaluates opportunities that could support its growth and long-term objectives, including partnerships, investments and acquisitions. Nu is highly confident and focused on its strategic priorities: deepening its position in Brazil, scaling

Con Edison is New York's Leading Engine for High-Quality Union Jobs NEW YORK, Sept. 30, 2026 /PRNewswire/ -- Con Edison generated $24.8 billion in total economic output and supported 39,700 jobs across New York State in 2025, according to a new economic impact report developed with HR&A Advisors.The report details how Con Edison's investments and operations support economic growth, strengthen local communities and advance a cleaner, more equitable energy future. The company provides reliable energy to 9.5 million people and more than 340,000 businesses across New York City and Westchester County."Con Edison is deeply connected to the communities we serve," said Matthew Ketschke, the presiden

TORONTO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Osisko Gold Group Inc. (NYSE:OGG, TSXV:OGG) ("Osisko Gold" or the "Company") is pleased to announce that it has completed its previously announced offering of US$600 million aggregate principal amount of 9.250% senior secured notes due 2031 (the "Notes"). The Notes will mature on October 1, 2031, and are non-callable for the first two years, and will pay interest semi-annually in arrears on April 1 and October 1 of each year, commencing on April 1, 2027. The Notes offering was completed on a private placement basis to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the United States Securities

Brings More Than 25 Years of Strong Financial Leadership Experience in Consumer-Facing Industries Levi Strauss & Co. (LS&Co.) (NYSE:LEVI) today announced the appointment of John Vandemore as Executive Vice President and Chief Financial Officer, effective November 1, 2026. "We are thrilled to welcome John at a pivotal moment for our company," said Michelle Gass, President and Chief Executive Officer of Levi Strauss & Co. "We are building a more direct-to-consumer business, unlocking the full potential of the Levi’s® brand and transforming LS&Co. into the world’s leading denim lifestyle retailer. John’s deep financial, operational and consumer experience, combined with his proven ability